BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32102660)

  • 1. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
    Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
    BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
    Li S; Ouyang J; Zhao B; An M; Wang L; Ding H; Zhang M; Han X
    BMC Infect Dis; 2020 Feb; 20(1):123. PubMed ID: 32046664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
    J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
    Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA
    AIDS Res Hum Retroviruses; 2016 Sep; 32(9):841-50. PubMed ID: 27346600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China.
    Chen X; Zou X; He J; Zheng J; Chiarella J; Kozal MJ
    PLoS One; 2016; 11(2):e0149215. PubMed ID: 26895182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
    Ayitewala A; Kyeyune F; Ainembabazi P; Nabulime E; Kato CD; Nankya I
    AIDS Res Ther; 2020 Jan; 17(1):2. PubMed ID: 32005262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure.
    Manosuthi W; Butler DM; Pérez-Santiago J; Poon AF; Pillai SK; Mehta SR; Pacold ME; Richman DD; Pond SK; Smith DM
    AIDS; 2010 Jan; 24(3):411-6. PubMed ID: 20009919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia.
    Indriati DW; Kotaki T; Khairunisa SQ; Witaningrum AM; Matondang MQY; Ueda S; Nasronudin ; Purnama A; Kurniawan D; Kameoka M
    Curr HIV Res; 2018; 16(2):158-166. PubMed ID: 29732988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.
    Wang Z; Zhao B; An M; Song W; Dong X; Li X; Wang L; Wang L; Tian W; Ding H; Han X
    BMC Infect Dis; 2021 Jul; 21(1):668. PubMed ID: 34243716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines.
    Salvana EMT; Samonte GMJ; Telan E; Leyritana K; Tactacan-Abrenica RJ; Ching PR; Arevalo GM; Dungca NT; Peñalosa-Ramos C; Mendoza KAR; Trinidad LF; Tonga AD; Lim J; Destura R; Alejandria M; Solante R; Arcangel L; Palaypayon NS; Schwem BE
    Int J Infect Dis; 2020 Jun; 95():125-132. PubMed ID: 32081778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
    Dong K; Ye L; Leng Y; Liang S; Feng L; Yang H; Su L; Li Y; Baloch S; He F; Yuan D; Pei X
    Tohoku J Exp Med; 2019 Jan; 247(1):1-12. PubMed ID: 30643108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore.
    Hsu LY; Subramaniam R; Bacheler L; Paton NI
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):5-13. PubMed ID: 15608517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
    Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
    Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
    Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
    Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
    PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China.
    Yang C; Liu S; Zhang T; Hou Y; Liu X; Gao Y; Yang G; Wang Z; Chen H; Li M; Zhu Z
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1723-8. PubMed ID: 22587343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.